Shows a significant drop in active drug shortages since mid-2025. As of Feb. 12, 2026, 80 medications were listed as being in shortage, down from 194 reported in June. The decline reflects ongoing updates to the FDA’s database, including manufacturing recoveries, regulatory changes, and revised shortage classifications rather than immediate supply conditions at hospitals.

Several medications were recently discontinued or affected, including antibiotics used for bacterial infections, treatments for hypertension and cholesterol management, therapies for Parkinson’s disease and movement disorders, antiviral medications, and ophthalmic solutions used in eye procedures. Manufacturers cited discontinuations of specific formulations and production changes as key reasons for the shortages.

The FDA continues to monitor supply disruptions and update its database regularly to track medication availability and manufacturing status.

Source: Becker’s Hospital Review  Ella Jeffries, “12 drugs in shortage,” February 2026.